SANUWAVE Health, Inc. (SNWV) stock
SNWVNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 10/30
$1.71+0.01 (+0.59%)
Close on Nov 18, 2026Market cap $14.71MP/E –Yield –
SANUWAVE Health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
SANUWAVE Health's revenue for the twelve months ending Jun 30, 2026 was $44.02M, up 12.7% year over year. For fiscal 2025 it was $44.05M, up 35.0% from the year before. Over ten years it grew 46.5% a year on average. The highest annual figure on record is $44.05M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.05M | +35.0% |
| FY2024 | Dec 31, 2024 | $32.63M | +60.0% |
| FY2023 | Dec 31, 2023 | $20.40M | +21.8% |
| FY2022 | Dec 31, 2022 | $16.74M | +28.7% |
| FY2021 | Dec 31, 2021 | $13.01M | +220.7% |
| FY2020 | Dec 31, 2020 | $4.06M | +294.4% |
| FY2019 | Dec 31, 2019 | $1.03M | -44.4% |
| FY2018 | Dec 31, 2018 | $1.85M | +150.5% |
| FY2017 | Dec 31, 2017 | $738.53K | -46.3% |
| FY2016 | Dec 31, 2016 | $1.38M | +42.5% |
| FY2015 | Dec 31, 2015 | $965.50K | +13.9% |
| FY2014 | Dec 31, 2014 | $847.37K | +5.9% |
| FY2013 | Dec 31, 2013 | $800.03K | +4.0% |
| FY2012 | Dec 31, 2012 | $769.22K | -4.2% |
| FY2011 | Dec 31, 2011 | $802.57K | +10.2% |
| FY2010 | Dec 31, 2010 | $728.45K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $9.74M | -3.1% |
| Q1 FY2026 | Mar 31, 2026 | $9.62M | +3.1% |
| Q4 FY2025 | Dec 31, 2025 | $13.39M | +29.7% |
| Q3 FY2025 | Sep 30, 2025 | $11.27M | +20.4% |
| Q2 FY2025 | Jun 30, 2025 | $10.05M | +40.4% |
| Q1 FY2025 | Mar 31, 2025 | $9.33M | +61.3% |
| Q4 FY2024 | Dec 31, 2024 | $10.33M | +47.6% |
| Q3 FY2024 | Sep 30, 2024 | $9.36M | +89.0% |
| Q2 FY2024 | Jun 30, 2024 | $7.16M | +53.2% |
| Q1 FY2024 | Mar 31, 2024 | $5.79M | +53.3% |
| Q4 FY2023 | Dec 31, 2023 | $6.99M | +27.2% |
| Q3 FY2023 | Sep 30, 2023 | $4.95M | +18.9% |
| Q2 FY2023 | Jun 30, 2023 | $4.68M | +20.4% |
| Q1 FY2023 | Mar 31, 2023 | $3.78M | +18.2% |
| Q4 FY2022 | Dec 31, 2022 | $5.50M | +29.1% |
| Q3 FY2022 | Sep 30, 2022 | $4.17M | +11.8% |
| Q2 FY2022 | Jun 30, 2022 | $3.88M | +33.4% |
| Q1 FY2022 | Mar 31, 2022 | $3.20M | +51.0% |
| Q4 FY2021 | Dec 31, 2021 | $4.26M | +73.2% |
| Q3 FY2021 | Sep 30, 2021 | $3.73M | +172.7% |
| Q2 FY2021 | Jun 30, 2021 | $2.91M | +3404.8% |
| Q1 FY2021 | Mar 31, 2021 | $2.12M | +1320.1% |
| Q4 FY2020 | Dec 31, 2020 | $2.46M | +631.5% |
| Q3 FY2020 | Sep 30, 2020 | $1.37M | +591.2% |
| Q2 FY2020 | Jun 30, 2020 | $83.00K | -73.8% |
| Q1 FY2020 | Mar 31, 2020 | $149.00K | -16.3% |
| Q4 FY2019 | Dec 31, 2019 | $336.15K | -26.4% |
| Q3 FY2019 | Sep 30, 2019 | $197.64K | -66.8% |
| Q2 FY2019 | Jun 30, 2019 | $316.98K | -30.1% |
| Q1 FY2019 | Mar 31, 2019 | $177.96K | -48.3% |
| Q4 FY2018 | Dec 31, 2018 | $456.79K | +44.4% |
| Q3 FY2018 | Sep 30, 2018 | $595.79K | +268.7% |
| Q2 FY2018 | Jun 30, 2018 | $453.21K | +308.1% |
| Q1 FY2018 | Mar 31, 2018 | $344.27K | +130.2% |
| Q4 FY2017 | Dec 31, 2017 | $316.33K | -51.2% |
| Q3 FY2017 | Sep 30, 2017 | $161.59K | -36.8% |
| Q2 FY2017 | Jun 30, 2017 | $111.05K | – |
| Q1 FY2017 | Mar 31, 2017 | $149.57K | – |
| Q4 FY2016 | Dec 31, 2016 | $647.68K | – |
| Q3 FY2016 | Sep 30, 2016 | $255.65K | – |
See a number that looks wrong?